StocksFin Logo
Jazz Pharmaceuticals plc country of incorporation
|
|
Mr. Bruce Cozadd
|
3,200 employees
NASDAQ | Healthcare | Biotechnology
NovoCure Limited country of incorporation
|
|
Mr. Asaf Danziger
|
1,167 employees
NASDAQ | Healthcare | Medical Instruments & Supplies
Q322 reported Nov 9, 2022 Reporting Period
$940.65M 12.2% vs. Q321 Revenues Q322
85.79% 3.8% vs. Q321 Gross Profit Margin
-2.09% ! 66.9% vs. Q321 Net Profit Margin
422.89M 54.3% vs. Q321 Free Cash Flow Q322
$-0.31 ! 64% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Oct 27, 2022 Reporting Period
$131M -2% vs. Q321 Revenues Q322
77.29% -0.1% vs. Q321 Gross Profit Margin
-20.29% ! -106.5% vs. Q321 Net Profit Margin
16.72M -31.5% vs. Q321 Free Cash Flow Q322
$-0.25 ! -92.3% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
1.85
7.62
Current Ratio
3.16
7.81
Cash Ratio
1.03
1.73
Price to Book
3.05
17.89
Price to Sales
8.9
60.83
Price to Earnings
-106.48
-74.97